YQH-14813-28375
3 vaccinations
6 coded responses
21 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 971 / OR
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-10
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tirednessFree text: I have lupus ra and MCTD so this is commonMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tirednessFree text: These are everyday symptoms for me with young kids and my diseaseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Fatigue or tirednessAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
- 2021-04-17
- 2021-04-24
- 2021-05-02
- 2021-05-08
- 2021-05-17
- 2021-05-24
-
2021-07-10
Survey response — 3 months, dose 1MedDRA: Diarrhoea, Medical counselling, Muscle spasms — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Loose bms for the last week and horrible cramps · Healthcare visit (other): Called my on call rheumatologist to see if medication brand change could be problem.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-10
Report sent to call center — 3 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-10-11
-
2021-12-12
Dose 2 — Moderna
-
2022-04-11
Dose 3 — Moderna
-
2022-04-12
Survey response — 12 months, dose 1MedDRA: Chills, Headache, Pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I got my second booster yesterday and today I have a fever, headache, body aches, and chillsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Survey response — days 1–6 daily, dose 3MedDRA: Pre-existing disease — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have lupus and have to stop my medication for 1week after getting vaccineMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Health check-in — day 7, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-25
- 2022-05-09
-
2022-05-16
Survey response — day 35, dose 3MedDRA: Norovirus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Noro virusMedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-12 | Moderna | No |
| 3 | 2022-04-11 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-10 | Successful 2021-07-13 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-05-16 | Successful 2022-05-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): I have lupus ra and MCTD so this is common
Systemic reaction (other): These are everyday symptoms for me with young kids and my disease
Release 9 — 3 months, dose 1
Symptoms: Loose bms for the last week and horrible cramps
Healthcare visit (other): Called my on call rheumatologist to see if medication brand change could be problem.
Release 11 — 12 months, dose 1
Symptoms: I got my second booster yesterday and today I have a fever, headache, body aches, and chills
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): I have lupus and have to stop my medication for 1week after getting vaccine
Release 11 — day 35, dose 3
Symptoms: Noro virus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Norovirus infection | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release